A Look At Big Pharma's Value Sensitivity To Changes In Tax Rates

With the U.S.'s new tax law coming into effect, many companies will see a significant impact from changes in their effective tax rates (some more than others). In this note, we focus on some of the major pharmaceutical firms such as Pfizer, Johnson & Johnson, Merck and Bristol-Myers Squibb.